CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients

Phase 2SNIPR001Positive
AI Analysis

Summary

SNIPR has enrolled the first patient in the Phase 2 portion of its SNIPR001 trial, expanding the study to 66 total patients.

Clinical Trial Data

Phase

Phase 2

Patients

66

Importance:5/10
Sentiment:
0.50
clinical trialPhase 2patient enrollment
Related Companies

Read the original article

Published by GlobeNewswire Clinical Studies on September 17, 2026 8:00 AM

Read Original